Discovery Partners International.
Discovery Partners International (Nasdaq: DPII) is a leader in collaborative drug discovery. DPI's integrated discovery framework encompasses a broad spectrum of capabilities in chemistry, biology, informatics, computational modeling and synthesis automation. DPI's approach to drug discovery places a heavy emphasis on up-front interdisciplinary analysis of its client's problems. By drawing on the collective expertise of its chemists, biologists and computational scientists, lead discovery and optimization strategies with the highest likelihood of success are formulated and then executed using the company's extensive capabilities and high output technology platforms.